← FDA DRUG APPROVALS

FDA ANDA · ANDA078692

CETIRIZINE HYDROCHLORIDE

Sponsor: SANDOZ

APPLICATION
ANDA078692
TYPE
ANDA
ORIGINAL APPROVAL
2008-02-14
LATEST ACTION
2025-08-01
ROUTE
ORAL
DOSAGE FORM
TABLET, CHEWABLE
MARKETING STATUS
Over-the-counter

Products

CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGYOver-the-counter
CETIRIZINE HYDROCHLORIDE 10MG · TABLET, CHEWABLE · ORAL
CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGYOver-the-counter
CETIRIZINE HYDROCHLORIDE 5MG · TABLET, CHEWABLE · ORAL

Approval history

2025-08-01Labeling · Supplement 16 · standardAP
2008-02-14OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →